NCT05066282View on ClinicalTrials.gov

Long-Term Safety and Effectiveness of MDMA-Assisted Therapy for PTSD

CompletedOBSERVATIONAL
Enrollment

186

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

May 16, 2024

Study Completion Date

May 21, 2024

Conditions
PTSD
Trial Locations (4)

94158

USCF, San Francisco

H2W1Y9

Dr. Simon Amar Inc, Montreal

Unknown

Beer Yaakov Mental Health Center, Be’er Ya‘aqov

Tel Hashomer, Tel Aviv

Sponsors

Lead Sponsor

Lykos Therapeutics
All Listed Sponsors
lead

Lykos Therapeutics

INDUSTRY